Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints

Diego Santos García, Teresa de Deus Fonticoba, Carlos C. Bartolomé, Maria J. Feal Painceiras, Jose M. Paz González, Cristina Martinez Miró, Silvia Jesús, Miguel Aguilar, Pau Pastor, Lluis Planellas, Marina Cosgaya, Juan Garcia Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernandez Vara, Iria Cabo-Lopez, Lydia Lopez Manzanares, Isabel Gonzalez Aramburu, Maria A. Ávila Rivera, Victor Gomez MayordomoVictor Nogueira, Victor Puente, Julio Dotor García-Soto, Carmen Borrué, Berta Solano Vila, Maria Álvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo Padilla, Juan C. Martinez Castrillo, Pilar Sanchez Alonso, M.G. Alonso Losada, Nuria Lopez Ariztegui, Itziar Gastón, Jaime Kulisevsky, Marta Blázquez Estrada, Manuel Seijo, Javier Ruiz Martínez, Caridad Valero, Monica Kurtis, Oriol de Fábregues, Jessica Gonzalez Ardura, Ruben Alonso Redondo, Carlos Ordás, Luis M. Lopez Diaz L., Darrian McAfee, Pablo Martinez-Martin, Pablo Mir, None Coppadis Study Group

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

2 Cites (Scopus)

Resum

Visual hallucinations (VH) and subjective cognitive complaints (SCC) are associated with cognitive impairment (CI) in Parkinson's disease. Our aims were to determine the association between VH and SCC and the risk of CI development in a cohort of patients with Parkinson's disease and normal cognition (PD-NC). Methods Patients with PD-NC (total score of >80 on the Parkinson's Disease Cognitive Rating Scale [PD-CRS]) recruited from the Spanish COPPADIS cohort from January 2016 to November 2017 were followed up after 2 years. Subjects with a score of ≥1 on domain 5 and item 13 of the Non-Motor Symptoms Scale at baseline (V0) were considered as "with SCC" and "with VH," respectively. CI at the 2-year follow-up (plus or minus 1 month) (V2) was defined as a PD-CRS total score of <81. At V0 (n=376, 58.2% males, age 61.14±8.73 years [mean±SD]), the frequencies of VH and SCC were 13.6% and 62.2%, respectively. VH were more frequent in patients with SCC than in those without: 18.8% (44/234) vs 4.9% (7/142), p<0.0001. At V2, 15.2% (57/376) of the patients had developed CI. VH presenting at V0 was associated with a higher risk of CI at V2 (odds ratio [OR]=2.68, 95% confidence interval=1.05-6.83, p=0.039) after controlling for the effects of age, disease duration, education, medication, motor and nonmotor status, mood, and PD-CRS total score at V0. Although SCC were not associated with CI at V2, presenting both VH and SCC at V0 increased the probability of having CI at V2 (OR=3.71, 95% confidence interval= 1.36-10.17, p=0.011). VH were associated with the development of SCC and CI at the 2-year follow-up in patients with PD-NC.
Idioma originalAnglès
Pàgines (de-a)344-357
Nombre de pàgines14
RevistaJournal of Clinical Neurology (Korea)
Volum19
Número4
DOIs
Estat de la publicacióPublicada - 2023

Fingerprint

Navegar pels temes de recerca de 'Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints'. Junts formen un fingerprint únic.

Com citar-ho